EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Febrile neutropenia caused by the rare organism Phytobacter: first Case Report from India

Anusha Mruthyunjaya Swamy, Prasenjit Das, Indrani Sarkar, Deepak Sundriyal, Amber Prasad, Saugata Hazra, Uttam Kumar Nath

Frontiers in Medicine · 03.03.2026 · 13

DOI: 10.3389/fmed.2026.1735688 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Medicine, online erschienen am 03.03.2026. Verfasst von Anusha Mruthyunjaya Swamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phytobacter diazotrophicus is an emerging opportunistic, Gram-negative bacterium, originally recognized as a nitrogen-fixing, plant-associated organism and increasingly implicated in nosocomial infections. We report the first documented case of bloodstream infection due to P . diazotrophicus in an elderly female breast cancer patient with chemotherapy-induced febrile neutropenia. Case presentation A 62-year-old woman with HER2-positive, cT4bN2M0 breast cancer receiving neoadjuvant trastuzumab, carboplatin, and docetaxel presented with fever, headache, profound fatigue, pallor, and retinal hemorrhages. Laboratory evaluation revealed severe pancytopenia, with a platelet count of 5 × 10⁹/L, an absolute neutrophil count of 0.294 × 10⁹/L, a total leukocyte count of 1.05 × 10⁹/L, and a hemoglobin level of 3.7 g/dL. Blood cultures grew non-lactose-fermented Gram-negative bacilli, initially identified as Pantoea species by the VITEK-2 system; however, 16S rDNA sequencing confirmed the organism as Phytobacter species. The patient was managed with blood component transfusions, filgrastim, and empirical piperacillin–tazobactam. Antimicrobial therapy was stopped on day 8, with recovery of blood counts noted by day 7. Subsequently, chemotherapy was resumed with trastuzumab and single-agent taxane at a reduced dose.

Conclusion

Gram-negative infections caused by phytobacteria are likely underreported with the automated VITEK-2 identification system. This first molecularly confirmed case of Phytobacter diazotrophicus identified by 16S rDNA sequencing in India underscores the need for heightened clinical awareness, prompt and accurate microbiological identification, and vigilance regarding antimicrobial resistance, especially in the immunocompromised population.

Schlagwörter

Stichwörter der Autor:innen

Phytobacterfebrile neutropeniaimmune-compromisednosocomialsepsis

Autor:innen und Institutionen

  • Department of Medical Oncology Haematology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Department of Biosciences and Bioengineering, Indian Institute of Technology, Roorkee, Uttarakhand, India.
  • Centre for Nanotechnology, Indian Institute of Technology, Roorkee, Uttarakhand, India.

Zitieren

APA

Swamy, A. M., Das, P., Sarkar, I., Sundriyal, D., Prasad, A., Hazra, S., & Nath, U. K. (2026). Febrile neutropenia caused by the rare organism Phytobacter: first Case Report from India. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1735688

Vancouver

Swamy AM, Das P, Sarkar I, Sundriyal D, Prasad A, Hazra S, et al. Febrile neutropenia caused by the rare organism Phytobacter: first Case Report from India. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1735688

BibTeX
@article{Swamy2026,
  author = {Swamy, Anusha Mruthyunjaya and Das, Prasenjit and Sarkar, Indrani and Sundriyal, Deepak and Prasad, Amber and Hazra, Saugata and Nath, Uttam Kumar},
  title = {Febrile neutropenia caused by the rare organism Phytobacter: first Case Report from India},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1735688}
}
Kostenlos starten →